Evidence-Based Advances in ENT in Daily Practice

Abstract

Otorhinolaryngology (ENT) has seen significant advances in diagnostic modalities, surgical techniques, and therapeutic interventions over the last decade. This review synthesizes recent high-quality evidence, focusing on epidemiology, pathophysiology, risk factors, clinical features, and management strategies of common and challenging ENT conditions. Emphasis is placed on integrating practical, guideline-based recommendations and highlighting the impact of emerging therapies on daily clinical practice. The review aims to provide healthcare professionals with a comprehensive and up-to-date resource for optimizing patient outcomes in the evolving landscape of ENT care.

Introduction

ENT disorders, encompassing diseases of the ear, nose, and throat, are among the most prevalent health concerns globally, affecting diverse age groups and significantly impacting quality of life. Recent years have witnessed a surge in scientific research, leading to paradigm shifts in both understanding and managing ENT conditions. This review article discusses the current evidence base, recent advances, and clinical guidelines that inform contemporary practice, equipping physicians and allied professionals with actionable insights for improved patient care.

Epidemiology / Disease Burden

ENT diseases contribute to a substantial burden worldwide, with conditions such as chronic rhinosinusitis (CRS), otitis media, allergic rhinitis, and head and neck cancers representing significant healthcare challenges. Chronic otitis media remains a leading cause of hearing loss in children, while sinonasal conditions affect up to 12% of adults. Head and neck squamous cell carcinoma incidence is rising, particularly oropharyngeal cancers associated with human papillomavirus (HPV) infection. Sleep-disordered breathing, including obstructive sleep apnea (OSA), has also increased in prevalence, reflecting changing demographics and rising obesity rates. This epidemiological shift underscores the need for ongoing surveillance and evidence-driven interventions.

Pathophysiology

The pathophysiology of ENT disorders is multifactorial and often involves complex interactions between genetic predisposition, environmental exposures, immune responses, and microbial factors. For example, CRS is characterized by persistent mucosal inflammation, epithelial dysfunction, and altered microbiota. Otitis media involves Eustachian tube dysfunction, impaired mucociliary clearance, and recurrent infections. Allergic rhinitis results from IgE-mediated hypersensitivity, whereas OSA arises from anatomical airway collapse and neuromuscular factors. Understanding these mechanisms is pivotal for targeted therapies and personalized medicine approaches.

Risk Factors

Key risk factors for ENT diseases include environmental allergens, tobacco smoke exposure, upper respiratory infections, immunodeficiency, anatomical variations, and genetic susceptibility. For head and neck cancers, significant risks are HPV infection, tobacco and alcohol use, and occupational exposures. OSA is associated with obesity, craniofacial abnormalities, and neuromuscular disorders. Early identification of modifiable risk factors remains central to prevention and intervention strategies.

Clinical Features

Clinical presentations in ENT are diverse and often overlap with other specialties. CRS typically presents with nasal obstruction, facial pain, and anosmia. Otitis media manifests as otalgia, hearing loss, and sometimes otorrhea. Allergic rhinitis is characterized by sneezing, rhinorrhea, and pruritus, while OSA presents as loud snoring, witnessed apneas, and daytime sleepiness. Head and neck malignancies may present with non-healing ulcers, dysphagia, hoarseness, or neck mass. Thorough history-taking and examination are crucial for timely diagnosis.

Diagnosis

Advances in diagnostic modalities have greatly enhanced the accuracy and early detection of ENT diseases. Nasal endoscopy, high-resolution computed tomography (CT), and magnetic resonance imaging (MRI) are standard for sinonasal and skull base evaluation. Audiometry and tympanometry are essential for ear disorders, while polysomnography is the gold standard for diagnosing OSA. Molecular and serological assays, including HPV testing, are now integral in head and neck oncology. Point-of-care ultrasonography is increasingly utilized for neck masses and airway assessment, adding value to clinical examination.

Treatment & Management

Management of ENT disorders is increasingly tailored to disease phenotype and patient characteristics. CRS is managed with saline irrigation, intranasal corticosteroids, and, in select cases, biologics targeting type 2 inflammation. Otitis media treatment includes antibiotics, tympanostomy tubes for recurrent cases, and vaccination for prevention. Allergic rhinitis management combines allergen avoidance, pharmacotherapy, and immunotherapy. OSA treatment options span continuous positive airway pressure (CPAP), mandibular advancement devices, weight reduction, and surgical interventions. Multidisciplinary care is emphasized, particularly in head and neck cancers, integrating surgery, radiotherapy, and chemotherapy as appropriate.

Recent Advances / Emerging Therapies

Recent breakthroughs in ENT include the introduction of monoclonal antibodies (e.g., dupilumab) for refractory CRS with nasal polyps, based on pivotal trials demonstrating significant symptom reduction and improved quality of life. Endoscopic ear surgery has minimized morbidity for chronic otitis cases. In head and neck oncology, immunotherapy with checkpoint inhibitors (e.g., pembrolizumab, nivolumab) has become standard in recurrent/metastatic settings, offering durable responses. Robotic-assisted and minimally invasive transoral surgeries have improved functional outcomes. Advances in genomics and precision medicine are informing risk stratification and targeted therapies, while digital health tools (e.g., AI-based sleep analysis) support earlier OSA detection.

Guideline Recommendations

Current guidelines from organizations such as the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS), European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), and National Comprehensive Cancer Network (NCCN) inform evidence-based practice. These guidelines stress the importance of phenotype-driven management in CRS, shared decision-making for otitis media interventions, and early integration of immunotherapy in eligible head and neck cancer patients. For OSA, multidisciplinary evaluation and tailored therapy selection are emphasized to optimize outcomes. Adherence to updated recommendations ensures alignment with best practices and improves patient safety.

Conclusion

The landscape of ENT practice is rapidly evolving, fueled by advances in research, diagnostics, and therapeutics. Evidence-based approaches, individualized patient care, and adherence to current guidelines remain cornerstones of optimal management. Ongoing research and innovation will continue to refine clinical strategies, offering hope for improved outcomes across the spectrum of ENT diseases. Clinicians must remain engaged with the latest evidence to deliver high-quality, patient-centered care in daily practice.